Company name: Panax Pharma
Description: Distributor and seller of medical cannabis. The company holds a medical cannabis growing license agreement giving it access up to 1,000 square meters of cultivatable space in the Vukoz Research Institute in the Czech Republic.
Year founded: 2014
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Country: Czech Republic
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by MGC Pharmaceuticals (AMX: MXC) for CZK 40.53 million on February 7, 2017. The transaction will enable MGC Pharma to develop new strains of medicinal cannabis for its genetic database along with enhancing its production capabilities.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 1.60
Last known valuation date: 07-Feb-2017